Vitamin K Shows Promise for Calciphylaxis
First-ever randomized controlled trial of a treatment for calciphylaxis demonstrated improvements in survival, pain, and lesion size.
Calciphylaxis
Vitamin K Antagonists, Liver Dysfunction Implicated in Calciphylaxis
In a small study, vitamin K antagonist use and liver dysfunction emerged as the most important factors in the development of calciphylaxis.
Calciphylaxis in CKD Patients Linked to Hypercoagulable Conditions
In patients with stage 5 chronic kidney disease, lupus anticoagulant and combined thrombophilia occur more frequently in those with versus without calciphylaxis, case-control study shows.
A Case of Calciphylaxis Without CKD or ESRD
A patient experienced painful skin ulcers despite having normal renal function.
Next post in NKF 2017 Spring Meeting
